share_log

民生证券4月25日发布研报称，给予成都先导（688222.SH）推荐评级。评级理由主要包括：1）DEL筛选和库定制业务恢复显著，持续提升新颖性和服务多元化；2）多元化技术平台逐渐展现商业化价值，强化公司新药发现和优化能力；3）研发投入聚焦平台升级迭代和重点管线，AI为药物开发加速提效。（每日经济新闻）

Minsheng Securities released a research report on April 25 stating that it gave Chengdu Xiandao (688222.SH) a recommended rating. The main reasons for the rating include: 1) the DEL screening and library customization business has recovered significantly,

Zhitong Finance ·  Apr 25 18:29
Minsheng Securities released a research report on April 25 stating that it gave Chengdu Xiandao (688222.SH) a recommended rating. The main reasons for the rating include: 1) the DEL screening and library customization business has recovered significantly, continuously improving novelty and service diversification; 2) the diversified technology platform gradually shows commercial value and strengthens the company's new drug discovery and optimization capabilities; 3) R&D investment focuses on platform upgrades and iterations and key pipelines, and AI accelerates the efficiency of drug development. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment